Apexian Pharmaceuticals
- John Barnard
Managing Director of Pearl Street Venture Funds and Co-founder of Apexian Pharmaceuticals, Inc. with extensive experience developing and exiting early-stage companies. Former investor and Board advisor to Colucid Pharmaceuticals, Inc. acquired by Eli Lilly and Company for $960M.
Org chart
This person is not in the org chart
Teams
This person is not in any teams
Offices
This person is not in any offices
Apexian Pharmaceuticals
Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.
Ad
Ad